TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
VCRE

Vicore Pharma Holding AB

Healthcare · Biotechnology

9.00$ -3.5% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement VCRE
Line item Q4 24 Q1 25 Q2 25 Q4 25 Q1 26 Q2 26 LTM
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
1,599.0% 8,826.0% 5,694.1% 26,978.0% 17,042.4% 5,370.6% 8,712.9%
332.4% 1,583.6% 806.2% 5,265.6% 3,573.4% 1,491.9% 1,820.6%
1,943.8% 10,362.9% 6,467.2% 32,011.0% 20,672.3% 6,882.8% 10,518.2%
-1,843.8% -10,262.9% -6,367.2% -31,911.0% -20,572.3% -6,782.8% -10,418.2%
0.0% 2,960.2% 830.5% 2,039.9% 106.8% 0.0% 475.7%
-1,647.6% -12,503.9% -6,607.3% -32,721.5% -18,028.2% -6,446.9% -10,113.8%
-1,647.6% -12,503.9% -6,607.3% -32,721.5% -18,042.5% -6,454.8% -10,119.0%
– – -5,776.8% -30,681.6% -17,921.4% -6,446.9% -9,638.1%

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?